Nasdaq
BNTX
BioNTech SE
- Health Care
- Germany
- Listed 2019
- 1 day
- −1.1%
- 1 month
- −3.3%
- 1 year
- −18.1%
$91.19 · Mkt cap $22.9B
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
BioNTech SE
$91.19 · Mkt cap $22.9B
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
BioNTech SE trades under the ticker BNTX on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2019. Its market capitalisation is $22.9B. The last closing price was $91.19, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −18.1%, and −3.3% over the past month. Returns are price returns and exclude dividends.
This page exists because BNTX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.